Showing results (1-10 of 148) with videos related to

Sort By:
Pageof 15
The American Journal of Cardiology|March 21, 2003
Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goalsJames Shepherd, Donald B Hunninghake, Philip Barter, et al.
Endocrinology and Metabolism Clinics of North America|May 26, 2004
Metabolic abnormalities: high-density lipoproteinsPhilip Barter
Atherosclerosis. Supplements|April 13, 2005
The inflammation: lipoprotein cyclePhilip Barter
Atherosclerosis. Supplements|July 11, 2006
Managing diabetic dyslipidaemia--beyond LDL-C:HDL-C and triglyceridesPhilip Barter
Atherosclerosis. Supplements|December 14, 2011
HDL-C: role as a risk modifierPhilip Barter
Clinical and Experimental Nephrology|September 21, 2013
Lipoprotein metabolism and CKD: overviewPhilip Barter
Atherosclerosis. Supplements|May 4, 2004
HDL: a recipe for longevityPhilip Barter
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
Anti-atherogenic effects of fibrates in type 2 diabetesPhilip Barter
Atherosclerosis. Supplements|January 26, 2012
Raising HDL-C can be achieved by both lifestyle changes and pharmacological means. IntroductionPhilip Barter
The American Journal of Cardiology|November 10, 2009
Lessons learned from the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trialPhilip Barter
Pageof 15